D. R. Aberle, A. M. Adams, C. D. Berg, W. C. Black, J. D. Clapp et al., Reduced lung-cancer mortality with low-dose computed tomographic screening, N. Engl. J. Med, vol.365, pp.395-409, 2011.

H. J. De-koning, C. M. Van-der-aalst, K. Haaf, and M. P. Oudkerk, Effects of Volume CT Lung Cancer Screening: Mortality Results of the NELSON Randomised-Controlled Population Based Trial, Proceedings of the IASLC World Conference on Lung Cancer, vol.13, p.185, 2018.

V. A. Moyer, On behalf of the U.S. Preventive Services Task Force. Screening for lung cancer: U.S. preventive services task force recommendation statement, Ann. Intern. Med, vol.160, pp.330-338, 2014.

C. , , 2019.

M. Oudkerk, A. Devaraj, R. Vliegenthart, T. Henzler, H. Prosch et al., European position statement on lung cancer screening, Lancet Oncol, vol.18, issue.17, pp.30861-30867, 2017.

L. S. Kinsinger, C. Anderson, J. Kim, M. Larson, S. H. Chan et al., Implementation of lung cancer screening in the Veterans Health Administration, JAMA Intern. Med, vol.177, pp.399-406, 2017.

D. Pham, S. Bhandari, M. Oechsli, C. M. Pinkston, and G. H. Kloecker, Lung cancer screening rates: Data from the lung cancer screening registry, J. Clin. Oncol, vol.36, p.6504, 2018.

J. E. Tonge, M. Atack, P. A. Crosbie, P. V. Barber, R. Booton et al., Push and pull in ever smokers lung screening uptake decision-making intentions, Health Expect, vol.13, p.968, 2018.

H. Autorité-de-santé, , 2019.

H. A. Katki, S. A. Kovalchik, C. D. Berg, L. C. Cheung, and A. K. Chaturvedi, Development and validation of risk models to select ever-smokers for ct lung cancer screening, JAMA J. Am. Med. Assoc, vol.315, pp.2300-2311, 2016.

T. J. Caverly, A. Fagerlin, R. S. Wiener, C. G. Slatore, N. T. Tanner et al., Comparison of Observed Harms and Expected Mortality Benefit for Persons in the Veterans Health Affairs Lung Cancer Screening Demonstration Project, JAMA Intern. Med, vol.178, pp.426-428, 2018.

P. B. Bach, E. B. Elkin, U. Pastorino, M. W. Kattan, A. I. Mushlin et al., Benchmarking lung cancer mortality rates in current and former smokers, Chest, vol.126, pp.1742-1749, 2004.

D. E. Wood, E. A. Kazerooni, S. L. Baum, G. A. Eapen, D. S. Ettinger et al., Lung cancer screening, version 3, JNCCN J. Natl. Compr. Cancer Netw, vol.16, pp.412-441, 2018.

A. El-baz, G. M. Beache, G. Farb, K. Suzuki, K. Okada et al., Computer-aided diagnosis systems for lung cancer: Challenges and methodologies, Int. J. Biomed. Imaging, p.942353, 2013.

A. Murphy, M. Skalski, and F. Gaillard, The utilisation of convolutional neural networks in detecting pulmonary nodules: A review, Br. J. Radiol, vol.91, 2018.

S. G. Armato-3rd, G. Mclennan, L. Bidaut, M. F. Mcnitt-gray, C. R. Meyer et al., The Lung Image Database Consortium (LIDC) and Image Database Resource Initiative (IDRI): A completed reference database of lung nodules on CT scans, Med. Phys, vol.38, pp.915-931, 2011.

. Kaggle, Kaggle Data Science Bowl, 2017.

F. Liao, M. Liang, Z. Li, X. Hu, and S. Song, Evaluate the Malignancy of Pulmonary Nodules Using the 3D Deep Leaky Noisy-or Network, IEEE Trans. Cybern, vol.14, pp.1-12, 2017.

M. Santarpia, A. Liguori, A. ;-d'aveni, N. Karachaliou, M. Gonzalez-cao et al., Liquid biopsy for lung cancer early detection, J. Thorac. Dis, vol.10, pp.882-897, 2018.

P. Hofman, Liquid biopsy for early detection of lung cancer, Curr. Opin. Oncol, vol.29, pp.73-78, 2017.

M. Ilie, V. Hofman, E. Long-mira, E. Selva, J. M. Vignaud et al., Sentinel" circulating tumor cells allow early diagnosis of lung cancer in patients with Chronic obstructive pulmonary disease, PLoS ONE, vol.9, p.111597, 2014.
URL : https://hal.archives-ouvertes.fr/hal-01687052

V. J. Hofman, M. Ilie, and P. M. Hofman, Detection and characterization of circulating tumor cells in lung cancer: Why and how? Cancer Cytopathol, vol.124, pp.380-387, 2016.

S. Leroy, J. Benzaquen, A. Mazzetta, S. Marchand-adam, B. Padovani et al., Circulating tumour cells as a potential screening tool for lung cancer (the AIR study): Protocol of a prospective multicentre cohort study in France, BMJ Open, vol.7, p.18884, 2017.
URL : https://hal.archives-ouvertes.fr/hal-01744875

M. B. Wozniak, G. Scelo, D. C. Muller, A. Mukeria, D. Zaridze et al., Circulating MicroRNAs as Non-Invasive Biomarkers for Early Detection of Non-Small-Cell Lung Cancer, PLoS ONE, vol.10, p.125026, 2015.

C. Sanfiorenzo, M. I. Ilie, A. Belaid, F. Barlési, J. Mouroux et al., Two Panels of Plasma MicroRNAs as Non-Invasive Biomarkers for Prediction of Recurrence in Resectable NSCLC, PLoS ONE, issue.8, p.54596, 2013.

M. Boeri, C. Verri, D. Conte, L. Roz, P. Modena et al., MicroRNA signatures in tissues and plasma predict development and prognosis of computed tomography detected lung cancer, Proc. Natl. Acad. Sci, vol.108, pp.3713-3718, 2011.

G. Sozzi, M. Boeri, M. Rossi, C. Verri, P. Suatoni et al., Clinical utility of a plasma-based miRNA signature classifier within computed tomography lung cancer screening: A correlative MILD trial study, J. Clin. Oncol, vol.32, pp.768-773, 2014.

F. Montani, M. J. Marzi, F. Dezi, E. Dama, R. M. Carletti et al., MiR-test: A blood test for lung cancer early detection, J. Natl. Cancer Inst, vol.107, p.63, 2015.

J. D. Cohen, L. Li, Y. Wang, C. Thoburn, B. Afsari et al., Detection and localization of surgically resectable cancers with a multi-analyte blood test, Science, vol.359, pp.926-930, 2018.

E. Billatos, J. L. Vick, M. E. Lenburg, and A. E. Spira, The airway transcriptome as a biomarker for early lung cancer detection, Clin. Cancer Res, vol.24, pp.2984-2992, 2018.

F. Guida, N. Sun, L. E. Bantis, D. C. Muller, P. Li et al., and the Integrative Analysis of Lung Cancer Etiology and Risk (INTEGRAL) Consortium for Early Detection of Lung Cancer. Assessment of Lung Cancer Risk on the Basis of a Biomarker Panel of Circulating Proteins, JAMA Oncol, 2018.

T. Jiang, S. Ren, and C. Zhou, Role of circulating-tumor DNA analysis in non-small cell lung cancer, Lung Cancer, vol.90, pp.128-134, 2015.

R. Lehmann-werman, D. Neiman, H. Zemmour, J. Moss, J. Magenheim et al., Identification of tissue-specific cell death using methylation patterns of circulating DNA, Proc. Natl. Acad. Sci, vol.113, pp.1826-1834, 2016.

M. Tomasetti, M. Amati, J. Neuzil, and L. Santarelli, Circulating epigenetic biomarkers in lung malignanciesFrom early diagnosis to therapy, Lung Cancer, vol.107, pp.65-72, 2017.

M. E. Levine, H. D. Hosgood, B. Chen, D. Absher, T. Assimes et al., DNA methylation age of blood predicts future onset of lung cancer in the women's health initiative, Aging, vol.7, pp.690-700, 2015.

K. Warton and G. Samimi, Methylation of cell-free circulating DNA in the diagnosis of cancer, Front. Mol. Biosci, vol.2, p.13, 2015.

A. Hulbert, I. Jusue-torres, A. Stark, C. Chen, K. Rodgers et al., Early detection of lung cancer using DNA promoter hypermethylation in plasma and sputum, Clin. Cancer Res, vol.23, 1998.

G. A. Silvestri, N. T. Tanner, P. Kearney, A. Vachani, P. P. Massion et al., Assessment of Plasma Proteomics Biomarker's Ability to Distinguish Benign from Malignant Lung Nodules: Results of the PANOPTIC (Pulmonary Nodule Plasma Proteomic Classifier, vol.154, pp.491-500, 2018.

P. P. Massion, G. F. Healey, L. J. Peek, L. Fredericks, H. F. Sewell et al., Autoantibody Signature Enhances the Positive Predictive Power of Computed Tomography and Nodule-Based Risk Models for Detection of Lung Cancer, J. Thorac. Oncol, vol.12, pp.578-584, 2017.

F. M. Sullivan, E. Farmer, F. S. Mair, S. Treweek, D. Kendrick et al., Detection in blood of autoantibodies to tumour antigens as a case-finding method in lung cancer using the EarlyCDT ®-Lung Test (ECLS): Study protocol for a randomized controlled trial, BMC Cancer, vol.17, p.187, 2017.

D. Ajona, M. Okrój, M. J. Pajares, J. Agorreta, M. D. Lozano et al., Complement C4d-specific antibodies for the diagnosis of lung cancer, Oncotarget, vol.9, pp.6346-6355, 2018.

M. Andolfi, R. Potenza, R. Capozzi, V. Liparulo, F. Puma et al., The role of bronchoscopy in the diagnosis of early lung cancer: A review, J. Thorac. Dis, vol.8, pp.3329-3337, 2016.

A. Mcwilliams, J. Mayo, S. Macdonald, J. C. Leriche, B. Palcic et al., Lung Cancer Screening. Am. J. Respir. Crit. Care Med, vol.168, pp.1167-1173, 2003.

A. M. Mcwilliams, J. R. Mayo, M. I. Ahn, S. L. Macdonald, and S. C. Lam, Lung cancer screening using multi-slice thin-section computed tomography and autofluorescence bronchoscopy, J. Thorac. Oncol, vol.1, pp.31514-31522, 2006.

A. Tremblay, N. Taghizadeh, A. M. Mcwilliams, P. Maceachern, D. R. Stather et al., Low Prevalence of High-Grade Lesions Detected with Autofluorescence Bronchoscopy in the Setting of Lung Cancer Screening in the Pan-Canadian Lung Cancer Screening Study, Chest, vol.150, pp.1015-1022, 2016.

O. Epelbaum and W. S. Aronow, Autofluorescence bronchoscopy for lung cancer screening: A time to reflect, Ann. Transl. Med, vol.4, 2016.